Sullivan & Cromwell Guides Bayer's $1.1B Conceptus Buy

Law360, New York (April 29, 2013, 1:51 PM EDT) -- Bayer AG on Monday said it will shell out $1.1 billion for California contraception company Conceptus Inc., shoring up its massive birth control division as generics pose increasingly intense threats to profits.

The deal gives Bayer a novel product called Essure — Conceptus' only offering — that's intended to permanently prevent pregnancy through use of a quick and minimally invasive procedure that blocks sperm from reaching and fertilizing an egg.

Within two weeks, Bayer plans to launch a tender offer valuing Conceptus at $31 per share,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.